Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Study type: Observational What is this?
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 08-001737
NCT ID: NCT00899275
Sponsor Protocol Number: AOST06B1
About this study
RATIONALE: Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
PURPOSE: The purpose of this study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.
See eligibility criteria
- All osteosarcoma patients seen at COG institutions are eligible, including the following:
- Newly diagnosed patients
- Patients with recurrent disease who were not enrolled at the time of diagnosis
- The following specimens from the initial biopsy (and/or definitive surgery if an up-front resection is performed) are required:
- Paraffin embedded block OR 30 unstained slides
- Pretreatment blood consisting of 5 mL serum, 10 mL plasma, and 10 mL heparinized whole blood
- Fresh and frozen tumor specimens
Prior Concurrent Therapy:
- Patients are not required to enter a therapeutic study to enroll on this study
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Carola A Arndt, M.D.
Open for enrollment
Cancer Center Clinical Trials Referral Office